Abstract:Lu Li, &ast Jiaqi Meng, &ast Jiquan Chen Department of Pulmonary and Critical Care Medicine, Third Affiliated Hospital of Naval Medical University, Shanghai, 200438, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jiquan Chen, Department of Pulmonary and Critical Care Medicine, Third Affiliated Hospital of Naval Medical University, Shanghai, 200438, People's Republic of China, Tel +86-13065135302, Email Objective: Chronic lung diseases (CLDs) are a major global health concern, characterized by a progressive decline in pulmonary function that severely impacts quality of life. It is essential to identify and predict the primary risk factors for CLDs. This study aims to establish a predictive model to assist healthcare providers in the early identification of high-risk patients and timely interventions and treatment options. Methods: This study utilized questionnaire data from the China Health and Retirement Longitudinal Study (CHARLS) collected in 2011, 2013, and 2015. A latent class growth model (LCGM) was established using CLDs as the baseline sample. This model stratified the patients based on the extent of the decline in Δpeak expiratory flow (ΔPEF), which served as the target variable. Independent variables included age, gender, smoking status, body mass index, education level, and comorbidities. A random forest model was developed using Python, and the importance of the feature was visualized through the SHAP method. The predictive performance of the model was evaluated using receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis. Results: After screening, a total of 553 patients with CLDs were included in the study. The random forest model pinpointed grip strength, age, education level, gender, and asthma as the top five risk factors for pulmonary function decline. Specifically, the model demonstrated robust predictive performance with an area under the ROC curve (AUC) value of 0.77, affirming its accuracy and clinical applicability. Both calibration and decision curves further substantiated the reliability of the model in identifying patients at increased risk for pulmonary function decline. Conclusion: The predictive model developed in this study serves as a valuable tool for clinicians to target early interventions and optimize treatment strategies to enhance the quality of care and patient outcomes in the management of CLDs. Keywords: chronic lung diseases, pulmonary function decline, latent class growth modeling, random forest model, health services, machine learning in healthcare Chronic lung diseases (CLDs), characterized mainly by chronic inflammation, structural changes, and functional impairment in the lungs, encompass various disease types such as chronic obstructive pulmonary disease (COPD), bronchial asthma, chronic bronchitis, and interstitial pneumonia. Currently, it is the third leading cause of death worldwide. 1 Chronic obstructive pulmonary disease (COPD) is a predominant contributor, accounting for 330 out of every 400 deaths attributed to CLDs. 1 This alarming issue is especially severe in the Western Pacific region. 2 In this context, the precise identification and prediction of factors leading to the decline in pulmonary function among patients with CLDs hold immense clinical and public health significance. The China Health and Retirement Longitudinal Study (CHARLS), a nationwide, large-scale longitudinal survey, provides valuable data resources to examine the health status of the middle-aged and older population in China, including various conditions such as CLDs and asthma. 3 COPD is a highly heterogeneous group of diseases characterized by symptoms such as dyspnea and coughing. 4,5 Although smoking is widely acknowledged as a significant risk factor, 2,4,5 The development and progression of COPD are influenced by a complex interplay of factors, including genetic predispositions, environmental pollutants, occupational hazards, chronic inflammation, and dysregulation of the lung microbiome. 2,4–6 Moreover, COPD is frequently associated with comorbid conditions, such as coronary artery disease, cognitive impairments, and psychological disorders. 7 This evidence points to the necessity of viewing C OPD as a systemic condition and highlights the need for comprehensive management strategies. Peak expiratory flow (PEF) is recognized as a critical indicator for assessing lung function in patients with COPD and has demonstrated superior predictive value for mortality compared to other pulmonary function tests. 8 Therefore, identifying the key factors influencing alterat -Abstract Truncated-

Circulating biomarkers of airflow limitation across the life span

Dynamic and prognostic proteomic associations with FEV1 decline in chronic obstructive pulmonary disease

Levels of Serum Biomarkers in COPD and the Association with Airflow Limitation

Serum Surfactant Protein D, Lung Function Decline, and Incident Chronic Obstructive Pulmonary Disease: a Longitudinal Study in Beijing

Distinct trajectories of lung function from childhood to mid-adulthood

Stratification of pre-COPD by lung volume indices creates distinct proteomic profiles in COPDGene cohort

Plasticity of Individual Lung Function States from Childhood to Adulthood

Integrated Single Cell Analysis of Human Lung Fibrosis Resolves Cellular Origins of Predictive Protein Signatures in Body Fluids

Predictors of lung function in early adulthood: A population-based cohort study

Telomere length in circulating leukocytes is associated with lung function and disease

Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study

LSC - 2024 - Epigenetic age acceleration and severity of airflow limitation on blood and lung tissue of COPD

Abstract P194: Proteomic Profiling of Pulmonary Function Decline and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities (ARIC) Study

Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent

A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease

Proteomics-based biomarkers in chronic obstructive pulmonary disease.

Risk Factors for FEV1 Decline in Mild COPD and High-Risk Populations

Metabolite signatures associated with microRNA miR-143-3p serve as drivers of poor lung function trajectories in childhood asthma

Longitudinal Analysis of Risk Factors for Pulmonary Function Decline in Chronic Lung Diseases Over Five Years

Proteomic predictors of mortality in stable COPD

Spirometric phenotypes from early childhood to young adulthood: a Chronic Airway Disease Early Stratification study